Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, TX, 78249, USA.
Department of Otolaryngology-Head and Neck Surgery, Brooke Army Medical Center, JBSA Fort Sam Houston, San Antonio, TX, USA.
Respir Res. 2024 Sep 28;25(1):351. doi: 10.1186/s12931-024-02973-1.
Laryngeal injury associated with traumatic or prolonged intubation may lead to voice, swallow, and airway complications. The interplay between inflammation and microbial population shifts induced by intubation may relate to clinical outcomes. The objective of this study was to investigate laryngeal mechanics, tissue inflammatory response, and local microbiome changes with laryngotracheal injury and localized delivery of therapeutics via drug-eluting endotracheal tube.
A simulated traumatic intubation injury was created in Yorkshire crossbreed swine under direct laryngoscopy. Endotracheal tubes electrospun with roxadustat or valacyclovir- loaded polycaprolactone (PCL) fibers were placed in the injured airway for 3, 7, or 14 days (n = 3 per group/time and ETT type). Vocal fold stiffness was then evaluated with normal indentation and laryngeal tissue sections were histologically examined. Immunohistochemistry and inflammatory marker profiling were conducted to evaluate the inflammatory response associated with injury and ETT placement. Additionally, ETT biofilm formation was visualized using scanning electron microscopy and micro-computed tomography, while changes in the airway microbiome were profiled through 16S rRNA sequencing.
Laryngeal tissue with roxadustat ETT placement had increasing localized stiffness outcomes over time and histological assessment indicated minimal epithelial ulceration and fibrosis, while inflammation remained severe across all timepoints. In contrast, vocal fold tissue with valacyclovir ETT placement showed no significant changes in stiffness over time; histological analysis presented a reduction in epithelial ulceration and inflammation scores along with increased fibrosis observed at 14 days. Immunohistochemistry revealed a decline in M1 and M2 macrophage markers over time for both ETT types. Among the cytokines, IL-8 levels differed significantly between the roxadustat and valacyclovir ETT groups, while no other cytokines showed statistically significant differences. Additionally, increased biofilm formation was observed in the coated ETTs with notable alterations in microbiota distinctive to each ETT type and across time.
The injured and intubated airway resulted in increased laryngeal stiffness. Local inflammation and the type of therapeutic administered impacted the bacterial composition within the upper respiratory microbiome, which in turn mediated local tissue healing and recovery.
与创伤或长时间插管相关的喉损伤可能导致声音、吞咽和气道并发症。插管引起的炎症和微生物种群变化之间的相互作用可能与临床结果有关。本研究的目的是通过气管内管局部给药来研究喉损伤和局部药物输送后喉的力学、组织炎症反应和局部微生物组的变化。
在直接喉镜下对约克郡杂交猪进行模拟创伤性插管损伤。将罗沙司他或伐昔洛韦负载聚己内酯(PCL)纤维的静电纺丝气管内管放置在受伤的气道中 3、7 或 14 天(每组/时间/气管内管类型各 3 只)。然后用正常压痕评估声带硬度,并对喉组织切片进行组织学检查。进行免疫组织化学和炎症标志物分析,以评估与损伤和气管内管放置相关的炎症反应。此外,通过扫描电子显微镜和微计算机断层扫描观察气管内管生物膜的形成,通过 16S rRNA 测序分析气道微生物组的变化。
罗沙司他气管内管放置的喉组织随时间推移出现僵硬度逐渐增加的局部表现,组织学评估表明上皮溃疡和纤维化程度轻微,而所有时间点的炎症仍很严重。相比之下,伐昔洛韦气管内管放置的声带组织在随时间推移没有明显的僵硬度变化;组织学分析显示上皮溃疡和炎症评分降低,14 天时观察到纤维化增加。免疫组织化学显示两种气管内管类型的 M1 和 M2 巨噬细胞标志物随时间减少。在细胞因子中,罗沙司他和伐昔洛韦气管内管组之间的 IL-8 水平有显著差异,而其他细胞因子无统计学差异。此外,在涂层气管内管中观察到生物膜形成增加,每种气管内管类型和随时间推移的微生物组成都有明显改变。
受伤和插管的气道导致喉僵硬度增加。局部炎症和给予的治疗类型影响上呼吸道微生物组中的细菌组成,进而介导局部组织愈合和恢复。